FindTrial
Sign In

Study on blood loss and coagulation and fibrinolysis function after TKA in plateau area patients

Study on blood loss and coagulation and fibrinolysis function after TKA in plateau area patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060414
Enrollment
Unknown
Registered
2022-05-31
Start date
2022-05-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

altitude group:None
plain group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-85 years; 2. BMI: 18 -- 35 kg/m^2; 3. ASA score I-III; 4. Knee flexion deformity or varus and valgus deformity; 5. Diagnosis of traumatic arthritis, rheumatoid arthritis, septic arthritis, or prior knee surgery.

Exclusion criteria

Exclusion criteria: 1. Coronary artery disease; 2. Kidney failure; 3. Lifelong anticoagulation or a history of anticoagulation; 4. Thrombolytic events (deep vein thrombosis, pulmonary embolus, myocardial infarction, cerebrovascular accident); 5. More than doubling of alanine aminotransferase (ALT or AST) or renal failure; 6. Preoperative low hemoglobin level (<110g/L).

Design outcomes

Primary

MeasureTime frame
blood loss;coagulation and fibrinolytic function;—

Countries

China

Contacts

Public ContactKang Pengde
kangpd@163.com+86 18280213153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026